About OncoCare: Connected Oncology Intelligence & Patient-Centric Care
OncoCare is India’s dedicated digital oncology platform engineered by Toshiko Health Private Limited. We bridge active cancer patients undergoing chemotherapy with their treating medical, surgical, and radiation oncologists through real-time CTCAE symptom triage, precision dosage automation, and virtual multidisciplinary tumor boards.
"Artificial intelligence technologies deployed in clinical oncology must preserve human autonomy, mandate clinician-in-the-loop oversight, provide explainable evidence trails, and enforce immediate safety escalation for critical toxicities."
Medical Advisory Council & Clinical Governance
OncoCare Medical Advisory Board
The OncoCare Medical Advisory Board is a multidisciplinary panel of surgical oncologists, medical oncologists, and health informatics technologists. Drawing on clinical practice across leading tertiary cancer institutions, the council oversees clinical safety architectures, CTCAE v5.0 acute toxicity triage cutoffs, and evidence-based chemotherapy protocol models powering OncoCare.
- Multidisciplinary Oversight: Surgical Oncology, Medical Oncology, Radiation Oncology, and Oncology Nursing.
- Clinical AI Focus: Explainable decision support, BSA/AUC dosage safety gating, and automated CTCAE grade 3/4 adverse event escalation.
- Ethical Governance: Direct stewards of OncoCare’s alignment with the ICMR 2023 National Ethical Guidelines for AI in Healthcare.
Our Core Clinical Pillars
Zero Black-Box Medical AI
Every protocol recommendation cites validated peer-reviewed evidence (NCCN, ASCO, ICMR). Registered Medical Practitioners (RMPs) review and authorize all clinical care actions.
Continuous CTCAE Toxicity Triage
Chemotherapy fever (100.4°F+), absolute neutrophil count (ANC) drops, and acute toxicities automatically trigger hospital emergency protocols for immediate intervention.
ABDM & DPDP Act Compliance
All patient data is encrypted with 256-bit AES vaults hosted in MeitY-empanelled Tier-IV data centers in Mumbai, facilitating frictionless ABHA digital health record exchange.
Corporate & Legal Identity
Corporate Identity Number (CIN): U47721MH2025PTC442215
Registered Office: FLAT NO.502, FLOOR.5, A WING, BHAKTI PARK, WADALA, Antop Hill, Mumbai - 400037, Maharashtra, India
Support Helpline: +91 22 31846644
Official Email: support@toshikohealth.com
Clinical & Regulatory References
- Indian Council of Medical Research (ICMR) — National Ethical Guidelines for Biomedical AI (2023).
- World Health Organization (WHO) — Global Oncology Quality & Early Diagnosis Standards.
- National Cancer Institute (NCI) — Common Terminology Criteria for Adverse Events (CTCAE v5.0).
- American Society of Clinical Oncology (ASCO) — Clinical Oncology Care Protocols & Biomarkers.
- National Health Authority (NHA) — Ayushman Bharat Digital Mission (ABDM) M1-M3 Specifications.